Cambridge Cancer Genomics
CCG.ai empowers clinicians to make personalised treatment strategies…
Y CombinatorSummer 2017InactiveHealthcareDiagnosticsGenomicsOncology
What they do
Problem
Clinicians lack reliable, data-driven guidance to choose the right cancer therapy for each patient based on clinical and genomic evidence.
Solution
The company builds software for precision oncology that analyzes clinical and genomic data to generate biomarkers and support personalized treatment decisions.
Who it's for
Oncologists and healthcare providers (e.g., hospitals and cancer clinics) treating cancer patients.
Founders
John Cassidy
Founder/CEO
Nirmesh Patel
Founder/Chief Scientific Officer
Scientist turned founder, trying to solve big problems and change the world!
Evaline Tsai
Founder/CPO
Company timeline
- Founded2015
- YC batchSummer 2017
- StatusInactive
- Team size25 people
- LocationCambridge, England, United Kingdom; England, United Kingdom
Similar startups
Persephone Biosciences
We are using the gut microbiome to end cancer.
Tmunity Therapeutics
“It’s hard to say ‘we want to cure cancer.’ We do. Sometimes it’s har…
Alpha-9 Oncology
Clinical-stage radiopharma pipeline of peptide-based, best-in-class o…
Yemaachi Biotechnology
Diversifying precision cancer diagnostics and treatments
Known Medicine
Combining 3D cell culture & AI to translate drugs to clinical success
Notable Labs
Personalized drug discovery for blood cancer.